GlassScriptPrepare for your visit
Molly Mcbride
Gynecology · New York, NY · NPI 1326136524
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$6,995.24
in general payments reported to CMS, 2019-2025 · $137 in 2025
The $137 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $1,636.78
- Agile Therapeutics, INC. $535.75
- Evofem Biosciences, INC. $431.94
- Avion Pharmaceuticals $345.13
- Myovant Sciences INC. $312.94
- Exeltis, USA INC. $271.34
Drugs and devices associated with these payments
Myfembree Lo Loestrin Fe Orilissa Xeomin Veozah Twirla Slynd Balcoltra Ova1 Phexxi Aptima Duavee
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Molly Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1308476/molly-mcbride